Innovation in Medicine
|Dates||25 - 30 August 2019|
|Deadline for application||1 July 2019|
|Partners||University of Groningen Centre of Entrepreneurship (UGCE)
Business Generator Groningen
Healthy Ageing Campus
|Faculties||Faculty of Medical Sciences
Faculty of Economics & Business
Medicine Summer School 2019
After a highly successful run in 2018, the Graduate School of Medical Sciences of the University Medical Center Groningen is delighted to be organising the fourth Industry Perspectives on Innovative Medicine (IPIM) Summer School in August 2019.
The IPIM Summer School takes place in Groningen, the Netherlands with the aim of teaching students about private sector priorities and the societal impact of their research, in order to help them to become fully equipped translational researchers.
The programme of the 2019 IPIM Summer School will be similar to the 2018 programme, and will be up come spring.
Industry Perspectives on Innovative Medicine (IPIM), is a one-week interactive school for advanced undergraduate and master students who want to learn about the broader, non-academic, setting of biomedical research.
IPIM provides participants with a unique opportunity to learn from different speakers from the private sector (e.g. Pharma, Drug Development, Biotech, Diagnostics and Food & Nutrition), as well as experts in the areas of Entrepreneurship, Intellectual Property Rights, and Research Funding.
Participants gain insight into non-academic decision making processes and the societal value of biomedical research. Additionally, they get experience in implementing new concepts in their research proposals, including customer value, competition, competitive advantage, and team importance.
The week-long school is split between guest speakers, site visits and interactive workshops, where students work with the experienced business coaches of the Groningen Business Generator in groups to form a business proposal based on some of their own research.
During the final day of IPIM participants present their group proposal as an investor pitch in front of an expert jury.
|Last modified:||25 February 2019 10.46 a.m.|